Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction

Condition:   Acute ST Segment Elevation Myocardial Infarction Interventions:   Biological: RPH-104 80 mg;   Drug: Placebo Sponsors:   R-Pharm Overseas, Inc.;   Cromos Pharma, LLC;   DM 365, LLC;   Keystat, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials